Oncology

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma
Kristen McParland, Eng-Siew Koh, Benjamin Kong, Hao-Wen Sim, Subotheni Thavaneswaran, Sonia Yip, Elizabeth H Barnes, Mandy L Ballinger, David M Thomas, Richard De Abreu Lourenco, John Simes, Lucille Sebastian, Patrick J Wheeler, Desma Spyridopoulos, Cynthia Hawkins, Marshall Pitz, Christopher O'Callaghan, Hui K Gan

BMJ Open Feb 2025, 15 (2) e087922; DOI: 10.1136/bmjopen-2024-087922
Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
Ting-Ya Yang, Min-Hsiang Chuang, Hong-Min Lin, Vin-Cent Wu, Heng-Chih Pan, Yun Chou, Jui-Yi Chen

BMJ Open Feb 2025, 15 (2) e092752; DOI: 10.1136/bmjopen-2024-092752
Examining the relationship between incidence and mortality for commonly diagnosed cancers in the USA: an observational study using population-based SEER database
Adewole S Adamson, Vishal R Patel, H Gilbert Welch

BMJ Open Feb 2025, 15 (2) e084955; DOI: 10.1136/bmjopen-2024-084955
Investigating processes to support and improve informed financial consent in Australian cancer services: an implementation process mapping study and analysis
Carolyn Mazariego, Raylene Cox, Elizabeth Kennedy, Kate Whittaker, Natalie Taylor, Megan Varlow

BMJ Open Feb 2025, 15 (2) e082622; DOI: 10.1136/bmjopen-2023-082622
Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK
Manuel Rodriguez-Justo, Wasat Mansoor, Thomas Bird, Martin Eatock, Naureen Starling, Philippe Taniere

BMJ Open Feb 2025, 15 (2) e094343; DOI: 10.1136/bmjopen-2024-094343
Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomes
Jun-Kyu Kim, Mi-Ae Jang, Jong Eun Park, Dongju Won, Jung-Sook Ha, Kyoung-Bo Kim, Boyoung Park, Sun-Young Kong

BMJ Open Feb 2025, 15 (2) e093905; DOI: 10.1136/bmjopen-2024-093905
Efficacy and safety of NeoAdjuvant chemotherapy with or without tIslelizumab followed by debulking surgery for oVarian cancEr (NAIVE study) in China: study protocol of an open-label, phase II, randomised controlled trial
Ying Zhu, Jing Fei, Xiaoqing Zhu, Jiaojiao Zhang, Jianwei Zhou, Zhigang Zhang

BMJ Open Feb 2025, 15 (2) e092545; DOI: 10.1136/bmjopen-2024-092545
Real-world outcomes in patients with melanoma brain metastasis: a US multisite retrospective chart review study of systemic treatments
Isabella C Glitza Oliva, Jennell Palaia, Leon A Sakkal, Divya Patel, Andriy Moshyk, Natalia Han, Shardul Odak, Jordana K Schmier, Ning Ning, Sunandana Chandra

BMJ Open Jan 2025, 15 (1) e091098; DOI: 10.1136/bmjopen-2024-091098
Clinicopathological and prognostic significance of the microcystic elongated and fragmented pattern in endometrial cancer: a systematic review and meta-analysis
Peng Jia, Baofeng Duan, Yan Zhang

BMJ Open Jan 2025, 15 (1) e092006; DOI: 10.1136/bmjopen-2024-092006
Remote symptom monitoring with patient-reported outcomes and nudges during lung cancer immunotherapy in China (PRO-NET): protocol for a randomised controlled trial
Yiqi Xia, Xiaolong Guan, Zhenyu Shi, Yanan Luo, Ping He

BMJ Open Jan 2025, 15 (1) e093374; DOI: 10.1136/bmjopen-2024-093374

Main menu

Oncology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Oncology

Pages